Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1978 May;13(5):762–769. doi: 10.1128/aac.13.5.762

In Vitro and In Vivo Studies of Ambruticin (W7783): New Class of Antifungal Antibiotics

Samuel M Ringel 1
PMCID: PMC352329  PMID: 666301

Abstract

Ambruticin is a cyclopropyl-pyran acid, representing a new class of antibiotics. It has a relatively broad antifungal spectrum in vitro and is highly active against dimorphic as well as filamentous organisms. Of 24 strains of dermatophytic fungi tested, the majority were susceptible to ambruticin at 0.049 μg/ml or less. The minimal inhibitory concentration for the systemic fungi Histoplasma capsulatum and Blastomyces dermatitidis was 0.049 to 0.39 μg/ml. Ambruticin is fungicidal for metabolizing cells of Microsporum fulvum and does not cause cell leakage of 260-nm absorbing material. The antibiotic is effective orally as well as topically in guinea pigs experimentally infected with Trichophyton mentagrophytes. In mice, a single oral dose of 75 mg/kg produced peak serum levels of 45 μg/ml in 1 h with a serum half-life of 3.1 h. Excretion of the antibiotic is principally by the biliary route.

Full text

PDF
762

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bennett J. E. Chemotherapy of systemic mycoses (first of two parts). N Engl J Med. 1974 Jan 3;290(1):30–32. doi: 10.1056/NEJM197401032900107. [DOI] [PubMed] [Google Scholar]
  2. D'ARCY P. F., HOWARD E. M., MUGGLETON P. W., TOWNSEND S. B. The anti-inflammatory action of griseofulvin in experimental animals. J Pharm Pharmacol. 1960 Nov;12:659–665. doi: 10.1111/j.2042-7158.1960.tb12727.x. [DOI] [PubMed] [Google Scholar]
  3. EL NAKEEB M. A., MCLELLAN W. L., Jr, LAMPEN J. O. ANTIBIOTIC ACTION OF GRISEOFULVIN ON DERMATOPHYTES. J Bacteriol. 1965 Mar;89:557–563. doi: 10.1128/jb.89.3.557-563.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Huber F. M., Gottlieb D. The mechanism of action of griseofulvin. Can J Microbiol. 1968 Feb;14(2):111–118. doi: 10.1139/m68-019. [DOI] [PubMed] [Google Scholar]
  5. Levine H. B. R34000, a dioxolane imidazole in the therapy for experimental coccidioidomycosis. Comparison with miconazole and econazole. Chest. 1976 Dec;70(6):755–759. doi: 10.1378/chest.70.6.755. [DOI] [PubMed] [Google Scholar]
  6. Levine H. B., Ringel S. M., Cobb J. M. Therapeutic properties of oral ambruticin (W7783) in experimental pulmonary coccidioidomycosis of mice. Chest. 1978 Feb;73(2):202–206. doi: 10.1378/chest.73.2.202. [DOI] [PubMed] [Google Scholar]
  7. ROTH F. J., Jr, SALLMAN B., BLANK H. In vitro studies of the antifungal antibiotic griseofulvin. J Invest Dermatol. 1959 Dec;33:403–418. doi: 10.1038/jid.1959.164. [DOI] [PubMed] [Google Scholar]
  8. Ringel S. M., Greenough R. C., Roemer S., Connor D., Gutt A. L., Blair B., Kanter G., von Strandtmann Ambruticin (W7783), a new antifungal antibiotic. J Antibiot (Tokyo) 1977 May;30(5):371–375. doi: 10.7164/antibiotics.30.371. [DOI] [PubMed] [Google Scholar]
  9. Sippel J. E., Levine H. B. Annulment of amphotericin B inhibition of Coccidioides immitis endospores. Effects on growth, respiration and morphogenesis. Sabouraudia. 1969 Oct;7(3):159–168. [PubMed] [Google Scholar]
  10. Sreedhara Swamy K. H., Sirsi M., Ramananda Rao G. R. Studies on the mechanism of action of miconazole: effect of miconazole on respiration and cell permeability of Candida albicans. Antimicrob Agents Chemother. 1974 Apr;5(4):420–425. doi: 10.1128/aac.5.4.420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Stevens D. A., Levine H. B., Deresinski S. C. Miconazole in coccidiodomycosis. II. Therapeutic and pharmacologic studies in man. Am J Med. 1976 Feb;60(2):191–202. doi: 10.1016/0002-9343(76)90428-9. [DOI] [PubMed] [Google Scholar]
  12. Sung J. P., Grendahl J. G., Levine H. B. Intravenous and intrathecal miconazole therapy for systemic mycoses. West J Med. 1977 Jan;126(1):5–13. [PMC free article] [PubMed] [Google Scholar]
  13. UTZ J. P. AMPHOTERICIN B TOXICITY; GENERAL SIDE EFFECTS. Ann Intern Med. 1964 Aug;61:340–343. doi: 10.7326/0003-4819-61-2-340. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES